Guest guest Posted July 3, 2011 Report Share Posted July 3, 2011 FDA Approves Lazanda® - First Fentanyl Nasal Spray - For The Management Of Breakthrough Pain In Cancer Patients http://www.medicalnewstoday.com/releases/230168.php Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.